DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 Europe

2 FDF Dossiers
2 Europe

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 Finished Drug Prices, 2 Annual Reports

globalSalesInformation
2 Finished Drug Prices
2 Annual Reports

MARKET PLACE

1 FDF Dossiers

marketPlace
1 FDF Dossiers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

1,509

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Edurant / truvada, Emtricitabine / rilpivirine /tenofovir disoproxil, Emtricitabine mixture with rilpivirine hydrochloride and tenofovir disoproxil fumarate, 847446-10-0

Molecular Formula

C₅₃H₆₃ClFN₁₄O₁₇PS

Molecular Weight

1285.6 g/mol

InChI Key

NEZNLHNPLRCSOG-FNZDRVHOSA-N

1 2D Structure

Edurant / Truvada

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid;4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride

2.1.2 InChI

InChI=1S/C22H18N6.C19H30N5O10P.C8H10FN3O3S.C4H4O4.ClH/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19;1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5;5-3(6)1-2-4(7)8;/h3-9,11-13H,1-2H3,(H2,25,26,27,28);7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1,5-6,13H,2-3H2,(H2,10,11,14);1-2H,(H,5,6)(H,7,8);1H/b4-3+;;;2-1+;/t;14-;5-,6+;;/m.10../s1

2.1.3 InChI Key

NEZNLHNPLRCSOG-FNZDRVHOSA-N

2.1.4 Canonical SMILES

CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N.CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C.C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F.C(=CC(=O)O)C(=O)O.Cl

2.1.5 Isomeric SMILES

CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N.C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F.C(=C/C(=O)O)\C(=O)O.Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Edurant / Truvada

2. Emtricitabine / Rilpivirine /tenofovir Disoproxil

3. Emtricitabine Mixture With Rilpivirine Hydrochloride And Tenofovir Disoproxil Fumarate

4. 847446-10-0

2.3 Create Date

2012-03-21

3 Chemical and Physical Properties

Molecular Formula	C₅₃H₆₃ClFN₁₄O₁₇PS
Molecular Weight	1285.6 g/mol
Hydrogen Bond Donor Count	8
Hydrogen Bond Acceptor Count	29
Rotatable Bond Count	26
Exact Mass	1284.3626506 g/mol
Monoisotopic Mass	1284.3626506 g/mol
Topological Polar Surface Area	471 Å²
Heavy Atom Count	88
Formal Charge	0
Complexity	1800
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	2
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	5

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Complera
PubMed Health	Emtricitabine/Rilpivirine/Tenofovir (By mouth)
Drug Classes	Antiretroviral Agent
Drug Label	COMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine hydrochloride, and tenofovir DF. EMTRIVA is the brand name for emtricitabine, a synthetic nucleoside analog of cytidine. EDURANT is the brand name for rilpivirine, a no...
Active Ingredient	tenofovir disoproxil fumarate; rilpivirine hydrochloride; Emtricitabine
Dosage Form	Tablet
Route	Oral
Strength	300mg; 200mg; eq 25mg base
Market Status	Prescription
Company	Gilead Sciences

2 of 2
Drug Name	Complera
PubMed Health	Emtricitabine/Rilpivirine/Tenofovir (By mouth)
Drug Classes	Antiretroviral Agent
Drug Label	COMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine hydrochloride, and tenofovir DF. EMTRIVA is the brand name for emtricitabine, a synthetic nucleoside analog of cytidine. EDURANT is the brand name for rilpivirine, a no...
Active Ingredient	tenofovir disoproxil fumarate; rilpivirine hydrochloride; Emtricitabine
Dosage Form	Tablet
Route	Oral
Strength	300mg; 200mg; eq 25mg base
Market Status	Prescription
Company	Gilead Sciences